Radnor Capital Management LLC boosted its stake in GE Vernova Inc. (NYSE:GEV – Free Report) by 3.5% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 16,386 shares of the company’s stock after acquiring an additional 552 shares during the quarter. Radnor Capital Management LLC’s holdings in GE Vernova were worth $4,178,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of GEV. Newport Trust Company LLC bought a new position in GE Vernova in the 2nd quarter valued at about $650,140,000. Bank of New York Mellon Corp bought a new position in GE Vernova in the 2nd quarter valued at about $537,674,000. Price T Rowe Associates Inc. MD bought a new position in GE Vernova in the 1st quarter valued at about $367,474,000. Marshall Wace LLP bought a new position in shares of GE Vernova during the 2nd quarter valued at about $399,770,000. Finally, Legal & General Group Plc bought a new position in shares of GE Vernova during the 2nd quarter valued at about $293,699,000.
GE Vernova Stock Performance
GEV stock opened at $315.58 on Wednesday. The firm has a 50 day simple moving average of $251.31 and a 200 day simple moving average of $198.81. GE Vernova Inc. has a 52 week low of $115.00 and a 52 week high of $316.45.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on GEV
GE Vernova Profile
GE Vernova LLC, an energy business company, generates electricity. It operates under three segments: Power, Wind, and Electrification. The Power segments generates and sells electricity through hydro, gas, nuclear, and steam power. Wind segment engages in the manufacturing and sale of wind turbine blades; and Electrification segment provides grid solutions, power conversion, solar, and storage solutions.
Read More
- Five stocks we like better than GE Vernova
- The Risks of Owning Bonds
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- Differences Between Momentum Investing and Long Term Investing
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- How to Use the MarketBeat Stock Screener
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Want to see what other hedge funds are holding GEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE Vernova Inc. (NYSE:GEV – Free Report).
Receive News & Ratings for GE Vernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE Vernova and related companies with MarketBeat.com's FREE daily email newsletter.